PanGen Biotech (Korea) Today
| 222110 Stock | KRW 6,110 60.00 0.97% |
Performance10 of 100
| Odds Of DistressLess than 31
|
PanGen Biotech is trading at 6110.00 as of the 24th of November 2024, a 0.97 percent decrease since the beginning of the trading day. The stock's open price was 6170.0. PanGen Biotech has about a 31 percent probability of financial distress in the next few years of operation but had a somewhat ok performance during the last 90 days. Equity ratings for PanGen Biotech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of December 2022 and ending today, the 24th of November 2024. Click here to learn more.
PanGen Biotech Inc. operates as a specialized biologics company in South Korea. The company was founded in 1999 and is based in Suwon, South Korea. PanGen is traded on Korean Securities Dealers Automated Quotations in South Korea. The company has 9.64 M outstanding shares. More on PanGen Biotech
Moving against PanGen Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
PanGen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. PanGen Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding PanGen Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Jae Jang |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
PanGen Biotech (222110) is traded on KOSDAQ in Korea and employs 7 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 59.88 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PanGen Biotech's market, we take the total number of its shares issued and multiply it by PanGen Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. PanGen Biotech operates under Healthcare sector and is part of Biotechnology industry. The entity has 9.64 M outstanding shares.
PanGen Biotech has accumulated about 8.9 B in cash with (3.32 B) of positive cash flow from operations.
Check PanGen Biotech Probability Of Bankruptcy
Ownership AllocationThe market capitalization of PanGen Biotech is W59.88 Billion. PanGen Biotech has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check PanGen Ownership Details
PanGen Biotech Risk Profiles
Although PanGen Biotech's alpha and beta are two of the key measurements used to evaluate PanGen Biotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.17 | |||
| Semi Deviation | 2.91 | |||
| Standard Deviation | 5.75 | |||
| Variance | 33.03 |
PanGen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in PanGen Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
| All Next | Launch Module |
Other Information on Investing in PanGen Stock
PanGen Biotech financial ratios help investors to determine whether PanGen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PanGen with respect to the benefits of owning PanGen Biotech security.